Rallybio Corporation , a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced the publication ...
The following is a summary of “Prophylactic versus restrictive platelet transfusion strategy in patients with haematological malignancies in the ICU setting, a propensity-score analysis,” published in ...
The health minister announced that blood components will be provided free to the patients and private hospitals can avail these services at a nominal price ...